Previous studies in lung, breast, and colorectal cancers have shown that aberrant HOXC11 activity disrupts normal cell cycle regulation, DNA repair, and apoptosis, thereby promoting unchecked cell proliferation and tumor progression [60–62]. Here, HOXC11 is linked to colorectal cancer.